Risk Models to Predict Hypertension: A Systematic Review
暂无分享,去创建一个
Mika Kivimäki | G. David Batty | M. Kivimäki | A. Kengne | G. Batty | J. Echouffo-Tcheugui | Andre P. Kengne | A. Kengne | Justin B. Echouffo-Tcheugui | G. D. Batty
[1] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[2] Douglas G Altman,et al. Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.
[3] A. Kraja,et al. Genetics of Hypertension and Cardiovascular Disease and Their Interconnected Pathways: Lessons from Large Studies , 2011, Current hypertension reports.
[4] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[5] A. Evans,et al. Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions , 2006, Annals of Internal Medicine.
[6] K. Chien,et al. Prediction models for the risk of new-onset hypertension in ethnic Chinese in Taiwan , 2011, Journal of Human Hypertension.
[7] N. Tangri,et al. A predictive model for progression of chronic kidney disease to kidney failure. , 2011, JAMA.
[8] R. Vasan,et al. The progression from hypertension to congestive heart failure. , 1996, JAMA.
[9] Daniel Levy,et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study , 2001, The Lancet.
[10] Devin M Mann,et al. Comparison of the Framingham Heart Study Hypertension Model With Blood Pressure Alone in the Prediction of Risk of Hypertension: The Multi-Ethnic Study of Atherosclerosis , 2010, Hypertension.
[11] J. Mckenney,et al. National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .
[12] K G M Moons,et al. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review , 2011, Heart.
[13] Olle Melander,et al. Prediction of Blood Pressure Changes Over Time and Incidence of Hypertension by a Genetic Risk Score in Swedes , 2013, Hypertension.
[14] M. Woodward,et al. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker , 2012, Heart.
[15] D. Levy,et al. A Risk Score for Predicting Near-Term Incidence of Hypertension: The Framingham Heart Study , 2008, Annals of Internal Medicine.
[16] M. Cho,et al. Predicting the Risk of Incident Hypertension in a Korean Middle‐Aged Population: Korean Genome and Epidemiology Study , 2013, Journal of clinical hypertension.
[17] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[18] M. Woodward,et al. Risk prediction models: II. External validation, model updating, and impact assessment , 2012, Heart.
[19] Oscar H Franco,et al. Blood Pressure in Adulthood and Life Expectancy With Cardiovascular Disease in Men and Women: Life Course Analysis , 2005, Hypertension.
[20] Neil J Stone,et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.
[21] Sudha Seshadri,et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. , 2002, JAMA.
[22] G. Mensah,et al. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. , 2005, Archives of internal medicine.
[23] Nader Rifai,et al. Multiple Biomarkers and the Risk of Incident Hypertension , 2007, Hypertension.
[24] K. Reynolds,et al. Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.
[25] Nancy R Cook,et al. Prediction of incident hypertension risk in women with currently normal blood pressure. , 2009, The American journal of medicine.
[26] K. Anderson,et al. Cardiovascular disease risk profiles. , 1991, American heart journal.
[27] D. Levy,et al. Relations of Matrix Remodeling Biomarkers to Blood Pressure Progression and Incidence of Hypertension in the Community , 2009, Circulation.
[28] S. Oparil,et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. , 2006, The New England journal of medicine.
[29] A. Rodgers,et al. Global burden of blood-pressure-related disease, 2001 , 2008, The Lancet.
[30] G David Batty,et al. Incremental Predictive Value of Adding Past Blood Pressure Measurements to the Framingham Hypertension Risk Equation: The Whitehall II Study , 2010, Hypertension.
[31] A. LaCroix,et al. The prediction of midlife coronary heart disease and hypertension in young adults: the Johns Hopkins multiple risk equations. , 1990, American journal of preventive medicine.
[32] Farzad Hadaegh,et al. A point-score system superior to blood pressure measures alone for predicting incident hypertension: Tehran Lipid and Glucose Study , 2011, Journal of hypertension.
[33] M. Jokela,et al. Validating the Framingham Hypertension Risk Score: Results From the Whitehall II Study , 2009, Hypertension.
[34] Anthony J Viera,et al. A Hypertension Risk Score for Middle‐Aged and Older Adults , 2010, Journal of clinical hypertension.
[35] Youfa Wang,et al. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. , 2004, Archives of internal medicine.
[36] B. Norrving,et al. Global atlas on cardiovascular disease prevention and control. , 2011 .
[37] P. Whelton,et al. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. , 2000, Hypertension.